Arbutus Biopharma
ABUS
#6207
Rank
NZ$1.41 B
Marketcap
NZ$7.38
Share price
-1.39%
Change (1 day)
26.69%
Change (1 year)

EPS for Arbutus Biopharma (ABUS)

EPS in 2025 (TTM): NZ-$0.44

According to Arbutus Biopharma 's latest financial reports the company's current EPS (TTM) is NZ-$0.45. In 2024 the company made an earnings per share (EPS) of NZ-$0.66 an increase over its 2023 EPS that were of NZ-$0.76.

EPS history for Arbutus Biopharma from 1998 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.44-33.2%
2024NZ-$0.66-13.64%
2023NZ-$0.76-4.35%
2022NZ-$0.80-44.58%
2021NZ-$1.44-17%
2020NZ-$1.73-65.4%
2019NZ-$5.00138.84%
2018NZ-$2.09-22.44%
2017NZ-$2.70-78.45%
2016NZ-$12.53424.64%
2015NZ-$2.39-20.19%
2014NZ-$2.9987.96%
2013NZ-$1.59-142.59%
2012NZ$3.74-342.7%
2011NZ-$1.54-25.82%
2010NZ-$2.0847.8%
2009NZ-$1.41-43.55%
2008NZ-$2.49158.91%
2007NZ-$0.96-111.88%
2006NZ$8.10-552.53%
2005NZ-$1.79-71.77%
2004NZ-$6.34-14.48%
2003NZ-$7.41-8.95%
2002NZ-$8.1470.07%
2001NZ-$4.7948.01%
2000NZ-$3.23-38.54%
1999NZ-$5.26-24.6%
1998NZ-$6.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
NZ-$0.10-76.92% Bahamas
NRC Health
NRC
NZ$1.21-369.23%๐Ÿ‡บ๐Ÿ‡ธ USA